Fidel A Desir1, Catherine R Lesko1, Richard D Moore2, Michael A Horberg3, Cherise Wong1, Heidi M Crane4, Michael Silverberg5, Jennifer E Thorne6, Beth Rachlis7, Charles Rabkin8, Angel M Mayor9, William C Mathews10, Keri N Althoff1. 1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore. 2. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore. 3. Division of Research, Kaiser Permanente Mid-Atlantic Research Group, Rockville, Maryland. 4. Division of Allergy and Infectious Diseases, University of Washington, Seattle. 5. Division of Research, Kaiser Permanente Northern California, Oakland. 6. Division of Ocular Immunology, Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland. 7. Dalla Lana School of Public Health, University of Toronto, Ontario, Canada. 8. National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 9. Department of Internal Medicine, Universidad Central del Caribe, Bayamon, Puerto Rico. 10. Department of Medicine, University of California, San Diego.
Abstract
BACKGROUND: The United States National HIV/AIDS Strategy established goals to reduce disparities in retention in human immunodeficiency virus (HIV) care, antiretroviral therapy (ART) use, and viral suppression. The impact of sex, age, and sexual HIV acquisition risk (ie, heterosexual vs same-sex contact) on the magnitude of HIV-related racial/ethnic disparities is not well understood. METHODS: We estimated age-stratified racial/ethnic differences in the 5-year restricted mean percentage of person-time spent in care, on ART, and virally suppressed among 19 521 women (21.4%), men who have sex with men (MSM; 59.0%), and men who have sex with women (MSW; 19.6%) entering HIV care in the North American AIDS Cohort Collaboration on Research and Design between 2004 and 2014. RESULTS: Among women aged 18-29 years, whites spent 12.0% (95% confidence interval [CI], 1.1%-20.2%), 9.2% (95% CI, .4%-20.4%), and 13.5% (95% CI, 2.7%-22.5%) less person-time in care, on ART, and virally suppressed, respectively, than Hispanics. Black MSM aged ≥50 years spent 6.3% (95% CI, 1.3%-11.7%), 11.0% (95% CI, 4.6%-18.1%), and 9.7% (95% CI, 3.6%-16.8%) less person-time in these stages, respectively, than white MSM ≥50 years of age. Among MSM aged 40-49 years, blacks spent 9.8% (95% CI, 2.4%-16.5%) and 11.9% (95% CI, 3.8%-19.3%) less person-time on ART and virally suppressed, respectively, than whites. CONCLUSIONS: Racial/ethnic differences in HIV care persist in specific populations defined by sex, age, and sexual HIV acquisition risk. Clinical and public health interventions that jointly target these demographic factors are needed.
BACKGROUND: The United States National HIV/AIDS Strategy established goals to reduce disparities in retention in human immunodeficiency virus (HIV) care, antiretroviral therapy (ART) use, and viral suppression. The impact of sex, age, and sexual HIV acquisition risk (ie, heterosexual vs same-sex contact) on the magnitude of HIV-related racial/ethnic disparities is not well understood. METHODS: We estimated age-stratified racial/ethnic differences in the 5-year restricted mean percentage of person-time spent in care, on ART, and virally suppressed among 19 521 women (21.4%), men who have sex with men (MSM; 59.0%), and men who have sex with women (MSW; 19.6%) entering HIV care in the North American AIDS Cohort Collaboration on Research and Design between 2004 and 2014. RESULTS: Among women aged 18-29 years, whites spent 12.0% (95% confidence interval [CI], 1.1%-20.2%), 9.2% (95% CI, .4%-20.4%), and 13.5% (95% CI, 2.7%-22.5%) less person-time in care, on ART, and virally suppressed, respectively, than Hispanics. Black MSM aged ≥50 years spent 6.3% (95% CI, 1.3%-11.7%), 11.0% (95% CI, 4.6%-18.1%), and 9.7% (95% CI, 3.6%-16.8%) less person-time in these stages, respectively, than white MSM ≥50 years of age. Among MSM aged 40-49 years, blacks spent 9.8% (95% CI, 2.4%-16.5%) and 11.9% (95% CI, 3.8%-19.3%) less person-time on ART and virally suppressed, respectively, than whites. CONCLUSIONS: Racial/ethnic differences in HIV care persist in specific populations defined by sex, age, and sexual HIV acquisition risk. Clinical and public health interventions that jointly target these demographic factors are needed.
Authors: Stephen J Gange; Mari M Kitahata; Michael S Saag; David R Bangsberg; Ronald J Bosch; John T Brooks; Liviana Calzavara; Steven G Deeks; Joseph J Eron; Kelly A Gebo; M John Gill; David W Haas; Robert S Hogg; Michael A Horberg; Lisa P Jacobson; Amy C Justice; Gregory D Kirk; Marina B Klein; Jeffrey N Martin; Rosemary G McKaig; Benigno Rodriguez; Sean B Rourke; Timothy R Sterling; Aimee M Freeman; Richard D Moore Journal: Int J Epidemiol Date: 2007-01-08 Impact factor: 7.196
Authors: Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming Journal: N Engl J Med Date: 2011-07-18 Impact factor: 91.245
Authors: Baligh R Yehia; Peter Rebeiro; Keri N Althoff; Allison L Agwu; Michael A Horberg; Hasina Samji; Sonia Napravnik; Kenneth Mayer; Ellen Tedaldi; Michael J Silverberg; Jennifer E Thorne; Ann N Burchell; Sean B Rourke; Anita Rachlis; Angel Mayor; Michael J Gill; Anne Zinski; Michael Ohl; Kathryn Anastos; Alison G Abraham; Mari M Kitahata; Richard D Moore; Kelly A Gebo Journal: J Acquir Immune Defic Syndr Date: 2015-04-01 Impact factor: 3.731
Authors: Keri N Althoff; Peter Rebeiro; John T Brooks; Kate Buchacz; Kelly Gebo; Jeffrey Martin; Robert Hogg; Jennifer E Thorne; Marina Klein; M John Gill; Timothy R Sterling; Baligh Yehia; Michael J Silverberg; Heidi Crane; Amy C Justice; Stephen J Gange; Richard Moore; Mari M Kitahata; Michael A Horberg Journal: Clin Infect Dis Date: 2014-01-23 Impact factor: 9.079
Authors: Peter F Rebeiro; Alison G Abraham; Michael A Horberg; Keri N Althoff; Baligh R Yehia; Kate Buchacz; Bryan M Lau; Timothy R Sterling; Stephen J Gange Journal: AIDS Patient Care STDS Date: 2017-02-27 Impact factor: 5.078
Authors: Heather Bradley; H Irene Hall; Richard J Wolitski; Michelle M Van Handel; Amy E Stone; Michael LaFlam; Jacek Skarbinski; Darrel H Higa; Joseph Prejean; Emma L Frazier; Roshni Patel; Ping Huang; Qian An; Ruiguang Song; Tian Tang; Linda A Valleroy Journal: MMWR Morb Mortal Wkly Rep Date: 2014-11-28 Impact factor: 17.586
Authors: Anna L Hotton; Yen-Tyng Chen; Phil Schumm; Aditya S Khanna; Russell Brewer; Britt Skaathun; Rodal S Issema; Santhoshini Ramani; Arthi Ramachandran; Jonathan Ozik; Kayo Fujimoto; Nina T Harawa; John A Schneider Journal: J Urban Health Date: 2020-10 Impact factor: 3.671
Authors: Parastu Kasaie; Cameron Stewart; Elizabeth Humes; Lucas Gerace; Jinbing Zhang; Michael J Silverberg; Michael A Horberg; Peter F Rebeiro; Emily P Hyle; Viviane D Lima; Cherise Wong; M John Gill; Kelly Gebo; Richard Moore; Mari M Kitahata; Keri N Althoff Journal: Ann Epidemiol Date: 2021-10-07 Impact factor: 3.797
Authors: Brittany A Shelton; Deirdre Sawinski; Paul A MacLennan; Wonjun Lee; Christina Wyatt; Girish Nadkarni; Huma Fatima; Shikha Mehta; Heidi M Crane; Paige Porrett; Bruce Julian; Richard D Moore; Katerina Christopoulos; Jeffrey M Jacobson; Elmi Muller; Joseph J Eron; Michael Saag; Inga Peter; Jayme E Locke Journal: EClinicalMedicine Date: 2022-09-17
Authors: L Cuzin; L Cotte; C Delpierre; C Allavena; M-A Valantin; D Rey; P Delobel; P Pugliese; F Raffi; A Cabié Journal: PLoS One Date: 2019-09-06 Impact factor: 3.240
Authors: Mary Jo Trepka; Diana M Sheehan; Rahel Dawit; Tan Li; Kristopher P Fennie; Merhawi T Gebrezgi; Petra Brock; Mary Catherine Beach; Robert A Ladner Journal: J Int Assoc Provid AIDS Care Date: 2020 Jan-Dec